Signal from the log
Flow Medical
6 M$ · United States · Medtech
Flow Medical, à Chicago, développe HELYX-PE, un cathéter qui diffuse un médicament anticaillot dans les artères du poumon tout en mesurant leur pression, contre l'embolie pulmonaire. Les investisseurs sont décrits comme des industriels du dispositif médical, sans être nommés.
Spotted
Announced on , logged by the watch of 2 November 2026.
- Operation
- Funding round
- Announced amount
- 6 M$
- Country
- United States
- Sector
- Medtech
What the log says
Editorial note, in French
Repérée par la collecte. Personne ne l'a encore instruite.
What is missing before publishing
- No fund is publicly named. It is the first condition of the selection bar: without a named investor there is no round to tell.
- The stage of the round is not disclosed. A letter is never inferred from an amount or a track record.
Provenance
Source divenewsletter
Logged on 2 November 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Spotted The collection saw this operation and logged it. Nobody has processed it yet, so what is shown is still an automatic reading of the source headline.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.